Publication | Open Access
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia
17
Citations
13
References
2021
Year
These data support further clinical development of this BsAb for first-in-human phase I clinical trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1